Maylen Farma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acerus Reports First Quarter 2021 Financial Results
Nachrichtenquelle: globenewswire
 |  13.05.2021, 13:30  | 
54 
 | 
0 
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period
ended March 31, 2021. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”).
Q1 - 2021 Highlights
Re-purchased all remaining NATESTO rights from Aytu Biopharma, allowing Acerus to build and leverage its commercial business across North America
Expanded NATESTO access to 20 countries across Europe, Central Asia and the Middle East through an agreement with Maylen Farma (“Maylen”), a firm ....

United States , United Arab Emirates , Saudi Arabia , Kingdom Of Saudi Arabia , Aytu Biopharma , Chris Witty , Ed Gudaitis , Aytu Bioscience , Maylen Farma , Health Canada Approval Status , Amneal Pharmaceuticals , Acerus Pharmaceuticals Corporation , Company Contact , First Generation Capital Inc , Health Canada , North America , Central Asia , Middle East , Chief Executive Officer , Three Months Ended March , Restated Agreement , Orange Book , North Macedonia , Arab Emirates , Health Canada Approval , New Drug Submission ,